APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gene Knockout Cell Line Construction Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Gene Knockout Cell Line Construction Service Market Outlook and Growth Opportunities 2026

16 April 2026Not stated

Choose your research edition.

Industry ResearchGene Knockout Cell Line Construction Service Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Gene Knockout Cell Line Construction Service Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Gene Knockout Cell Line Construction Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gene Knockout Cell Line Construction Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Gene Knockout Cell Line Construction Service Market Analysis and Forecast 2026-2032227 pages · $4,950 USD

Market perspective

The global Gene Knockout Cell Line Construction Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Gene Knockout Cell Line Construction Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gene Knockout Cell Line Construction Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gene Knockout Cell Line Construction Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Gene Knockout Cell Line Construction Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Gene Knockout Cell Line Construction Service market include OriGene, Creative Bioarray, Horizon Discovery, Synthego, Cyagen, Cellecta, BiologicsCorp, Kyinno Bio and Porton Advanced, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Gene Knockout Cell Line Construction Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gene Knockout Cell Line Construction Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gene Knockout Cell Line Construction Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Gene Knockout Cell Line Construction Service market.

Gene Knockout Cell Line Construction Service Segment by Company

OriGene

Creative Bioarray

Horizon Discovery

Synthego

Cyagen

Cellecta

BiologicsCorp

Kyinno Bio

Porton Advanced

Cytosurge

AcceGen

System Biosciences

Altogen Labs

Syd Labs

Lifeasible

GenScript

Ubigene

Beyotime

Abace Biotechnology

Viewsolid Biotechnology

iGeneBio

VectorBuilder

BrainVTA

Gene Knockout Cell Line Construction Service Segment by Type

CRISPR/Cas9

TALEN

Others

Gene Knockout Cell Line Construction Service Segment by Application

Academic and Research Institutions

Pharmaceutical and Biotechnology Companies

Gene Knockout Cell Line Construction Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Gene Knockout Cell Line Construction Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Gene Knockout Cell Line Construction Service key companies, revenue, market share, and recent developments.

3. To split the Gene Knockout Cell Line Construction Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Gene Knockout Cell Line Construction Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Gene Knockout Cell Line Construction Service significant trends, drivers, influence factors in global and regions.

6. To analyze Gene Knockout Cell Line Construction Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Knockout Cell Line Construction Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gene Knockout Cell Line Construction Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Knockout Cell Line Construction Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gene Knockout Cell Line Construction Service industry.

Chapter 3: Detailed analysis of Gene Knockout Cell Line Construction Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Gene Knockout Cell Line Construction Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Gene Knockout Cell Line Construction Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Gene Knockout Cell Line Construction Service Industry Trends Table 2. Gene Knockout Cell Line Construction Service Industry Drivers Table 3. Gene Knockout Cell Line Construction Service Industry Opportunities and Challenges Table 4. Gene Knockout Cell Line Construction Service Industry Restraints Table 5. Global Gene Knockout Cell Line Construction Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Gene Knockout Cell Line Construction Service Revenue Share by Company (2021-2026) Table 7. Global Gene Knockout Cell Line Construction Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Gene Knockout Cell Line Construction Service Key Company Manufacturing Base & Headquarters Table 9. Global Gene Knockout Cell Line Construction Service Company, Product Type & Application Table 10. Global Gene Knockout Cell Line Construction Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Gene Knockout Cell Line Construction Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of CRISPR/Cas9 Table 15. Significant Companies of TALEN Table 16. Significant Companies of Others Table 17. Global Gene Knockout Cell Line Construction Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Gene Knockout Cell Line Construction Service Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Gene Knockout Cell Line Construction Service Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Gene Knockout Cell Line Construction Service Sales Value Share by Type (2021-2026) Table 21. Global Gene Knockout Cell Line Construction Service Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Academic and Research Institutions Table 23. Significant Companies of Pharmaceutical and Biotechnology Companies Table 24. Global Gene Knockout Cell Line Construction Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Gene Knockout Cell Line Construction Service Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Gene Knockout Cell Line Construction Service Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Gene Knockout Cell Line Construction Service Sales Value Share by Application (2021-2026) Table 28. Global Gene Knockout Cell Line Construction Service Sales Value Share by Application (2027-2032) Table 29. Global Gene Knockout Cell Line Construction Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Gene Knockout Cell Line Construction Service Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Gene Knockout Cell Line Construction Service Sales Value Share by Region (2021-2026) Table 32. Global Gene Knockout Cell Line Construction Service Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Gene Knockout Cell Line Construction Service Sales Value Share by Region (2027-2032) Table 34. Global Gene Knockout Cell Line Construction Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Gene Knockout Cell Line Construction Service Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Gene Knockout Cell Line Construction Service Sales Value Market Share by Country (2021-2026) Table 37. Global Gene Knockout Cell Line Construction Service Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Gene Knockout Cell Line Construction Service Sales Value Market Share by Country (2027-2032) Table 39. OriGene Company Information Table 40. OriGene Business Overview Table 41. OriGene Gene Knockout Cell Line Construction Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. OriGene Gene Knockout Cell Line Construction Service Product Portfolio Table 43. OriGene Recent Development Table 44. Creative Bioarray Company Information Table 45. Creative Bioarray Business Overview Table 46. Creative Bioarray Gene Knockout Cell Line Construction Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Creative Bioarray Gene Knockout Cell Line Construction Service Product Portfolio Table 48. Creative Bioarray Recent Development Table 49. Horizon Discovery Company Information Table 50. Horizon Discovery Business Overview Table 51. Horizon Discovery Gene Knockout Cell Line Construction Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Horizon Discovery Gene Knockout Cell Line Construction Service Product Portfolio Table 53. Horizon Discovery Recent Development Table 54. Synthego Company Information Table 55. Synthego Business Overview Table 56. Synthego Gene Knockout Cell Line Construction Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Synthego Gene Knockout Cell Line Construction Service Product Portfolio Table 58. Synthego Recent Development Table 59. Cyagen Company Information Table 60. Cyagen Business Overview Table 61. Cyagen Gene Knockout Cell Line Construction Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Cyagen Gene Knockout Cell Line Construction Service Product Portfolio Table 63. Cyagen Recent Development Table 64. Cellecta Company Information Table 65. Cellecta Business Overview Table 66. Cellecta Gene Knockout Cell Line Construction Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Cellecta Gene Knockout Cell Line Construction Service Product Portfolio Table 68. Cellecta Recent Development Table 69. BiologicsCorp Company Information Table 70. BiologicsCorp Business Overview Table 71. BiologicsCorp Gene Knockout Cell Line Construction Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. BiologicsCorp Gene Knockout Cell Line Construction Service Product Portfolio Table 73. BiologicsCorp Recent Development Table 74. Kyinno Bio Company Information Table 75. Kyinno Bio Business Overview Table 76. Kyinno Bio Gene Knockout Cell Line Construction Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Kyinno Bio Gene Knockout Cell Line Construction Service Product Portfolio Table 78. Kyinno Bio Recent Development Table 79. Porton Advanced Company Information Table 80. Porton Advanced Business Overview Table 81. Porton Advanced Gene Knockout Cell Line Construction Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Porton Advanced Gene Knockout Cell Line Construction Service Product Portfolio Table 83. Porton Advanced Recent Development Table 84. Cytosurge Company Information Table 85. Cytosurge Business Overview Table 86. Cytosurge Gene Knockout Cell Line Construction Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Cytosurge Gene Knockout Cell Line Construction Service Product Portfolio Table 88. Cytosurge Recent Development Table 89. AcceGen Company Information Table 90. AcceGen Business Overview Table 91. AcceGen Gene Knockout Cell Line Construction Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. AcceGen Gene Knockout Cell Line Construction Service Product Portfolio Table 93. AcceGen Recent Development Table 94. System Biosciences Company Information Table 95. System Biosciences Business Overview Table 96. System Biosciences Gene Knockout Cell Line Construction Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. System Biosciences Gene Knockout Cell Line Construction Service Product Portfolio Table 98. System Biosciences Recent Development Table 99. Altogen Labs Company Information Table 100. Altogen Labs Business Overview Table 101. Altogen Labs Gene Knockout Cell Line Construction Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Altogen Labs Gene Knockout Cell Line Construction Service Product Portfolio Table 103. Altogen Labs Recent Development Table 104. Syd Labs Company Information Table 105. Syd Labs Business Overview Table 106. Syd Labs Gene Knockout Cell Line Construction Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Syd Labs Gene Knockout Cell Line Construction Service Product Portfolio Table 108. Syd Labs Recent Development Table 109. Lifeasible Company Information Table 110. Lifeasible Business Overview Table 111. Lifeasible Gene Knockout Cell Line Construction Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Lifeasible Gene Knockout Cell Line Construction Service Product Portfolio Table 113. Lifeasible Recent Development Table 114. GenScript Company Information Table 115. GenScript Business Overview Table 116. GenScript Gene Knockout Cell Line Construction Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. GenScript Gene Knockout Cell Line Construction Service Product Portfolio Table 118. GenScript Recent Development Table 119. Ubigene Company Information Table 120. Ubigene Business Overview Table 121. Ubigene Gene Knockout Cell Line Construction Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Ubigene Gene Knockout Cell Line Construction Service Product Portfolio Table 123. Ubigene Recent Development Table 124. Beyotime Company Information Table 125. Beyotime Business Overview Table 126. Beyotime Gene Knockout Cell Line Construction Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Beyotime Gene Knockout Cell Line Construction Service Product Portfolio Table 128. Beyotime Recent Development Table 129. Abace Biotechnology Company Information Table 130. Abace Biotechnology Business Overview Table 131. Abace Biotechnology Gene Knockout Cell Line Construction Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. Abace Biotechnology Gene Knockout Cell Line Construction Service Product Portfolio Table 133. Abace Biotechnology Recent Development Table 134. Viewsolid Biotechnology Company Information Table 135. Viewsolid Biotechnology Business Overview Table 136. Viewsolid Biotechnology Gene Knockout Cell Line Construction Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. Viewsolid Biotechnology Gene Knockout Cell Line Construction Service Product Portfolio Table 138. Viewsolid Biotechnology Recent Development Table 139. iGeneBio Company Information Table 140. iGeneBio Business Overview Table 141. iGeneBio Gene Knockout Cell Line Construction Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. iGeneBio Gene Knockout Cell Line Construction Service Product Portfolio Table 143. iGeneBio Recent Development Table 144. VectorBuilder Company Information Table 145. VectorBuilder Business Overview Table 146. VectorBuilder Gene Knockout Cell Line Construction Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 147. VectorBuilder Gene Knockout Cell Line Construction Service Product Portfolio Table 148. VectorBuilder Recent Development Table 149. BrainVTA Company Information Table 150. BrainVTA Business Overview Table 151. BrainVTA Gene Knockout Cell Line Construction Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 152. BrainVTA Gene Knockout Cell Line Construction Service Product Portfolio Table 153. BrainVTA Recent Development Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Gene Knockout Cell Line Construction Service Product Image Figure 2. Global Gene Knockout Cell Line Construction Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gene Knockout Cell Line Construction Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Gene Knockout Cell Line Construction Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. CRISPR/Cas9 Image Figure 8. TALEN Image Figure 9. Others Image Figure 10. Global Gene Knockout Cell Line Construction Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Gene Knockout Cell Line Construction Service Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Gene Knockout Cell Line Construction Service Sales Value Share by Type (2021-2032) Figure 13. Academic and Research Institutions Image Figure 14. Pharmaceutical and Biotechnology Companies Image Figure 15. Global Gene Knockout Cell Line Construction Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Gene Knockout Cell Line Construction Service Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Gene Knockout Cell Line Construction Service Sales Value Share by Application (2021-2032) Figure 18. Global Gene Knockout Cell Line Construction Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Gene Knockout Cell Line Construction Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Gene Knockout Cell Line Construction Service Sales Value (2021-2032) & (US$ Million) Figure 21. North America Gene Knockout Cell Line Construction Service Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Gene Knockout Cell Line Construction Service Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Gene Knockout Cell Line Construction Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Gene Knockout Cell Line Construction Service Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Gene Knockout Cell Line Construction Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Gene Knockout Cell Line Construction Service Sales Value (2021-2032) & (US$ Million) Figure 27. South America Gene Knockout Cell Line Construction Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Gene Knockout Cell Line Construction Service Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Gene Knockout Cell Line Construction Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • CRISPR/Cas9
  • TALEN
  • Others
Applications
  • Academic and Research Institutions
  • Pharmaceutical and Biotechnology Companies
Companies covered
  • OriGene
  • Creative Bioarray
  • Horizon Discovery
  • Synthego
  • Cyagen
  • Cellecta
  • BiologicsCorp
  • Kyinno Bio
  • Porton Advanced
  • Cytosurge
  • AcceGen
  • System Biosciences
  • Altogen Labs
  • Syd Labs
  • Lifeasible
  • GenScript
  • Ubigene
  • Beyotime
  • Abace Biotechnology
  • Viewsolid Biotechnology
  • iGeneBio
  • VectorBuilder
  • BrainVTA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Gene Knockout Cell Line Construction Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Gene Knockout Cell Line Construction Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Gene Knockout Cell Line Construction Service Market Dynamics
  1. 2.1 Gene Knockout Cell Line Construction Service Industry Trends
  2. 2.2 Gene Knockout Cell Line Construction Service Industry Drivers
  3. 2.3 Gene Knockout Cell Line Construction Service Industry Opportunities and Challenges
  4. 2.4 Gene Knockout Cell Line Construction Service Industry Restraints
3 Gene Knockout Cell Line Construction Service Market by Company
  1. 3.1 Global Gene Knockout Cell Line Construction Service Company Revenue Ranking in 2025
  2. 3.2 Global Gene Knockout Cell Line Construction Service Revenue by Company (2021-2026)
  3. 3.3 Global Gene Knockout Cell Line Construction Service Company Ranking (2024-2026)
  4. 3.4 Global Gene Knockout Cell Line Construction Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Gene Knockout Cell Line Construction Service Company Product Type and Application
  6. 3.6 Global Gene Knockout Cell Line Construction Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Gene Knockout Cell Line Construction Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Gene Knockout Cell Line Construction Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Gene Knockout Cell Line Construction Service Market by Type
  1. 4.1 Gene Knockout Cell Line Construction Service Type Introduction
  2. 4.1.1 CRISPR/Cas9
  3. 4.1.2 TALEN
  4. 4.1.3 Others
  5. 4.2 Global Gene Knockout Cell Line Construction Service Sales Value by Type
  6. 4.2.1 Global Gene Knockout Cell Line Construction Service Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Gene Knockout Cell Line Construction Service Sales Value by Type (2021-2032)
  8. 4.2.3 Global Gene Knockout Cell Line Construction Service Sales Value Share by Type (2021-2032)
5 Gene Knockout Cell Line Construction Service Market by Application
  1. 5.1 Gene Knockout Cell Line Construction Service Application Introduction
  2. 5.1.1 Academic and Research Institutions
  3. 5.1.2 Pharmaceutical and Biotechnology Companies
  4. 5.2 Global Gene Knockout Cell Line Construction Service Sales Value by Application
  5. 5.2.1 Global Gene Knockout Cell Line Construction Service Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Gene Knockout Cell Line Construction Service Sales Value by Application (2021-2032)
  7. 5.2.3 Global Gene Knockout Cell Line Construction Service Sales Value Share by Application (2021-2032)
6 Gene Knockout Cell Line Construction Service Regional Value Analysis
  1. 6.1 Global Gene Knockout Cell Line Construction Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Gene Knockout Cell Line Construction Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Gene Knockout Cell Line Construction Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Gene Knockout Cell Line Construction Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Gene Knockout Cell Line Construction Service Sales Value (2021-2032)
  7. 6.3.2 North America Gene Knockout Cell Line Construction Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Gene Knockout Cell Line Construction Service Sales Value (2021-2032)
  10. 6.4.2 Europe Gene Knockout Cell Line Construction Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Gene Knockout Cell Line Construction Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Gene Knockout Cell Line Construction Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Gene Knockout Cell Line Construction Service Sales Value (2021-2032)
  16. 6.6.2 South America Gene Knockout Cell Line Construction Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Gene Knockout Cell Line Construction Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Gene Knockout Cell Line Construction Service Sales Value Share by Country, 2025 VS 2032
7 Gene Knockout Cell Line Construction Service Country-level Value Analysis
  1. 7.1 Global Gene Knockout Cell Line Construction Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Gene Knockout Cell Line Construction Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Gene Knockout Cell Line Construction Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Gene Knockout Cell Line Construction Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Gene Knockout Cell Line Construction Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Gene Knockout Cell Line Construction Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Gene Knockout Cell Line Construction Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 OriGene
  2. 8.1.1 OriGene Company Information
  3. 8.1.2 OriGene Business Overview
  4. 8.1.3 OriGene Gene Knockout Cell Line Construction Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 OriGene Gene Knockout Cell Line Construction Service Product Portfolio
  6. 8.1.5 OriGene Recent Developments
  7. 8.2 Creative Bioarray
  8. 8.2.1 Creative Bioarray Company Information
  9. 8.2.2 Creative Bioarray Business Overview
  10. 8.2.3 Creative Bioarray Gene Knockout Cell Line Construction Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Creative Bioarray Gene Knockout Cell Line Construction Service Product Portfolio
  12. 8.2.5 Creative Bioarray Recent Developments
  13. 8.3 Horizon Discovery
  14. 8.3.1 Horizon Discovery Company Information
  15. 8.3.2 Horizon Discovery Business Overview
  16. 8.3.3 Horizon Discovery Gene Knockout Cell Line Construction Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Horizon Discovery Gene Knockout Cell Line Construction Service Product Portfolio
  18. 8.3.5 Horizon Discovery Recent Developments
  19. 8.4 Synthego
  20. 8.4.1 Synthego Company Information
  21. 8.4.2 Synthego Business Overview
  22. 8.4.3 Synthego Gene Knockout Cell Line Construction Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Synthego Gene Knockout Cell Line Construction Service Product Portfolio
  24. 8.4.5 Synthego Recent Developments
  25. 8.5 Cyagen
  26. 8.5.1 Cyagen Company Information
  27. 8.5.2 Cyagen Business Overview
  28. 8.5.3 Cyagen Gene Knockout Cell Line Construction Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cyagen Gene Knockout Cell Line Construction Service Product Portfolio
  30. 8.5.5 Cyagen Recent Developments
  31. 8.6 Cellecta
  32. 8.6.1 Cellecta Company Information
  33. 8.6.2 Cellecta Business Overview
  34. 8.6.3 Cellecta Gene Knockout Cell Line Construction Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cellecta Gene Knockout Cell Line Construction Service Product Portfolio
  36. 8.6.5 Cellecta Recent Developments
  37. 8.7 BiologicsCorp
  38. 8.7.1 BiologicsCorp Company Information
  39. 8.7.2 BiologicsCorp Business Overview
  40. 8.7.3 BiologicsCorp Gene Knockout Cell Line Construction Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 BiologicsCorp Gene Knockout Cell Line Construction Service Product Portfolio
  42. 8.7.5 BiologicsCorp Recent Developments
  43. 8.8 Kyinno Bio
  44. 8.8.1 Kyinno Bio Company Information
  45. 8.8.2 Kyinno Bio Business Overview
  46. 8.8.3 Kyinno Bio Gene Knockout Cell Line Construction Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Kyinno Bio Gene Knockout Cell Line Construction Service Product Portfolio
  48. 8.8.5 Kyinno Bio Recent Developments
  49. 8.9 Porton Advanced
  50. 8.9.1 Porton Advanced Company Information
  51. 8.9.2 Porton Advanced Business Overview
  52. 8.9.3 Porton Advanced Gene Knockout Cell Line Construction Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Porton Advanced Gene Knockout Cell Line Construction Service Product Portfolio
  54. 8.9.5 Porton Advanced Recent Developments
  55. 8.10 Cytosurge
  56. 8.10.1 Cytosurge Company Information
  57. 8.10.2 Cytosurge Business Overview
  58. 8.10.3 Cytosurge Gene Knockout Cell Line Construction Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Cytosurge Gene Knockout Cell Line Construction Service Product Portfolio
  60. 8.10.5 Cytosurge Recent Developments
  61. 8.11 AcceGen
  62. 8.11.1 AcceGen Company Information
  63. 8.11.2 AcceGen Business Overview
  64. 8.11.3 AcceGen Gene Knockout Cell Line Construction Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 AcceGen Gene Knockout Cell Line Construction Service Product Portfolio
  66. 8.11.5 AcceGen Recent Developments
  67. 8.12 System Biosciences
  68. 8.12.1 System Biosciences Company Information
  69. 8.12.2 System Biosciences Business Overview
  70. 8.12.3 System Biosciences Gene Knockout Cell Line Construction Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 System Biosciences Gene Knockout Cell Line Construction Service Product Portfolio
  72. 8.12.5 System Biosciences Recent Developments
  73. 8.13 Altogen Labs
  74. 8.13.1 Altogen Labs Company Information
  75. 8.13.2 Altogen Labs Business Overview
  76. 8.13.3 Altogen Labs Gene Knockout Cell Line Construction Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Altogen Labs Gene Knockout Cell Line Construction Service Product Portfolio
  78. 8.13.5 Altogen Labs Recent Developments
  79. 8.14 Syd Labs
  80. 8.14.1 Syd Labs Company Information
  81. 8.14.2 Syd Labs Business Overview
  82. 8.14.3 Syd Labs Gene Knockout Cell Line Construction Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Syd Labs Gene Knockout Cell Line Construction Service Product Portfolio
  84. 8.14.5 Syd Labs Recent Developments
  85. 8.15 Lifeasible
  86. 8.15.1 Lifeasible Company Information
  87. 8.15.2 Lifeasible Business Overview
  88. 8.15.3 Lifeasible Gene Knockout Cell Line Construction Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Lifeasible Gene Knockout Cell Line Construction Service Product Portfolio
  90. 8.15.5 Lifeasible Recent Developments
  91. 8.16 GenScript
  92. 8.16.1 GenScript Company Information
  93. 8.16.2 GenScript Business Overview
  94. 8.16.3 GenScript Gene Knockout Cell Line Construction Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 GenScript Gene Knockout Cell Line Construction Service Product Portfolio
  96. 8.16.5 GenScript Recent Developments
  97. 8.17 Ubigene
  98. 8.17.1 Ubigene Company Information
  99. 8.17.2 Ubigene Business Overview
  100. 8.17.3 Ubigene Gene Knockout Cell Line Construction Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Ubigene Gene Knockout Cell Line Construction Service Product Portfolio
  102. 8.17.5 Ubigene Recent Developments
  103. 8.18 Beyotime
  104. 8.18.1 Beyotime Company Information
  105. 8.18.2 Beyotime Business Overview
  106. 8.18.3 Beyotime Gene Knockout Cell Line Construction Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Beyotime Gene Knockout Cell Line Construction Service Product Portfolio
  108. 8.18.5 Beyotime Recent Developments
  109. 8.19 Abace Biotechnology
  110. 8.19.1 Abace Biotechnology Company Information
  111. 8.19.2 Abace Biotechnology Business Overview
  112. 8.19.3 Abace Biotechnology Gene Knockout Cell Line Construction Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Abace Biotechnology Gene Knockout Cell Line Construction Service Product Portfolio
  114. 8.19.5 Abace Biotechnology Recent Developments
  115. 8.20 Viewsolid Biotechnology
  116. 8.20.1 Viewsolid Biotechnology Company Information
  117. 8.20.2 Viewsolid Biotechnology Business Overview
  118. 8.20.3 Viewsolid Biotechnology Gene Knockout Cell Line Construction Service Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Viewsolid Biotechnology Gene Knockout Cell Line Construction Service Product Portfolio
  120. 8.20.5 Viewsolid Biotechnology Recent Developments
  121. 8.21 iGeneBio
  122. 8.21.1 iGeneBio Company Information
  123. 8.21.2 iGeneBio Business Overview
  124. 8.21.3 iGeneBio Gene Knockout Cell Line Construction Service Revenue and Gross Margin (2021-2026)
  125. 8.21.4 iGeneBio Gene Knockout Cell Line Construction Service Product Portfolio
  126. 8.21.5 iGeneBio Recent Developments
  127. 8.22 VectorBuilder
  128. 8.22.1 VectorBuilder Company Information
  129. 8.22.2 VectorBuilder Business Overview
  130. 8.22.3 VectorBuilder Gene Knockout Cell Line Construction Service Revenue and Gross Margin (2021-2026)
  131. 8.22.4 VectorBuilder Gene Knockout Cell Line Construction Service Product Portfolio
  132. 8.22.5 VectorBuilder Recent Developments
  133. 8.23 BrainVTA
  134. 8.23.1 BrainVTA Company Information
  135. 8.23.2 BrainVTA Business Overview
  136. 8.23.3 BrainVTA Gene Knockout Cell Line Construction Service Revenue and Gross Margin (2021-2026)
  137. 8.23.4 BrainVTA Gene Knockout Cell Line Construction Service Product Portfolio
  138. 8.23.5 BrainVTA Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst